Our understanding of psychedelics' effects on the brain is expanding rapidly, with over 400 clinical trials currently ...

The Atturra (ASX: ATA) share price has dropped below the Atturra IPO price of $0.50 after pathetic H1 FY 2026 Atturra results ...

As Pentagon policy interpreted as "divorce" from Europe, what is Australia's place in the post-Iran attack security scenario?

Following a text from Joe Rogan on ibogaine's benefits for opiate addiction, Trump texted back, "Do you want FDA approval?

One Nation hitting its ceiling at 20-25% on primary vote polling, as focus groups suggest support consolidating around ...

I (Growthgauge here) have been following the turnaround of Kip McGrath Education Centres for a couple of years now, and you can find my earlier articles here. Below, I’ve sketched out the turnaround ...

Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...

Cuscal (ASX: CCL) is the leading payments infrastructure provider in Australia, outside of the major banks. Established in 1966 by a group of credit unions, it has grown from its mutual roots into a ...

Last time I covered the FY25 results here, I indicated that this didn’t seem like a one-year transition. Instead, it felt like a two-to-three-year adjustment period before the business could return to ...

AV networking technology provider Audinate Group Ltd (ASX:AD8) released their full year 2024 financial results today, following on from their update earlier in the month. Revenue of US $60 million was ...